KELOWNA, BC / ACCESSWIRE / February 21, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce additional findings from its human clinical study HYPER-H21-4 ("the Study") demonstrating a potentially novel mechanism of action of its patented DehydraTECH-processed cannabidiol ("CBD") capsule formulation… Read More..

Company Seeks Approval for Reverse Stock Split to Maintain Nasdaq Listing NEW YORK, NY - (NewMediaWire) - January 12, 2023 - PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (Nasdaq: SNGX) is on track to deliver a safe and effective front-line treatment to a community of patients living with a… Read More..

LAS VEGAS, NV / ACCESSWIRE / January 11, 2023 / SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a "Sky Technologies") ("SKYX," "we" or "the Company"), a highly disruptive platform technology company with more than 60 issued and pending patents globally, today announced that the SkyPlug Smart won a total of five prestigious awards from leading technology publications,… Read More..